Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo

Inflammation Research

Volumn 59, Issue 7, 2010, Pages 571-578

  Subramaniyam, Devipriya ^a   Steele, Chad ^c   Köhnlein, Thomas ^a   Welte, Tobias ^a   Grip, Olof ^b   Matalon, Sadis ^d   Janciauskiene, Sabina ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c and Clinical Center   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Acute phase proteins; Alpha 1 antitrypsin; Cytokines; Endotoxin; Inflammation

Indexed keywords

ALPHA 1 ANTITRYPSIN; ENDOTOXIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LUNG HOMOGENATE; MALE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; TRACHEOBRONCHIAL TOILET; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; LUNG; LUNG LAVAGE;

ALPHA 1-ANTITRYPSIN; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CYTOKINES; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED C57BL; MONOCYTES; NEUTROPHILS; PNEUMONIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955702672     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0164-x     Document Type: Article

References (47)

1. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621-36.
2. Heinrich PC, Horn F, Graeve L, Dittrich E, Kerr I, Muller-Newen G, et al. Interleukin-6 and related cytokines: effect on the acute phase reaction. Z Ernahrungswiss. 1998;37(suppl 1):43-9.
3. Dabbagh K, Laurent GJ, Shock A, Leoni P, Papakrivopoulou J, Chambers RC. Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J Cell Physiol. 2001;186:73-81.
4. Janciauskiene S, Zelvyte I, Jansson L, Stevens T. Divergent effects of alpha1-antitrypsin on neutrophil activation, in vitro. Biochem Biophys Res Commun. 2004;315:288-96.
5. Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med. 1993;178:1629-36.
6. Libert C, Van Molle W, Brouckaert P, Fiers W. Alpha1-antitrypsin inhibits the lethal response to TNF in mice. J Immunol. 1996;157:5126-9.
7. Churg A, Dai J, Zay K, Karsan A, Hendricks R, Yee C, et al. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest. 2001;81:1119-31.
8. Dhami R, Gilks B, Xie C, Zay K, Wright JL, Churg A. Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by alpha1-antitrypsin. Am J Respir Cell Mol Biol. 2000;22:244-52.
9. Cantin AM, Woods DE. Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Am J Respir Crit Care Med. 1999;160:1130-5.
10. Griese M, Latzin P, Kappler M, Weckerle K, Heinzlmaier T, Bernhardt T, et al. Alpha1-antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. Eur Respir J. 2007;29:240-50.
11. Lewis EC, Shapiro L, Bowers OJ, Dinarello CA. Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci USA. 2005;102:12153-8.
12. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine. 1992;4:361-8.
13. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82:513-20.
14. Zouki C, Beauchamp M, Baron C, Filep JG. Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. J Clin Invest. 1997;100:522-9.
15. Dobrinich R, Spagnuolo PJ. Binding of C-reactive protein to human neutrophils. Inhibition of respiratory burst activity. Arthritis Rheum. 1991;34:1031-8.
16. Pue CA, Mortensen RF, Marsh CB, Pope HA, Wewers MD. Acute phase levels of reactive protein enhance IL-1 beta and IL- 1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages. J Immunol. 1996;156:1594-600.
17. Boutten A, Dehoux M, Deschenes M, Rouzeau JD, Bories PN, Durand G. Alpha 1-acid glycoprotein potentiates lipopolysaccharide- induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. Eur J Immunol. 1992;22:2687-95.
18. Su SJ, Yang BC, Wang YS, Yeh TM. Alpha 1-acid glycoproteininduced tumor necrosis factor-alpha secretion of human monocytes is enhanced by serum binding proteins and depends on protein tyrosine kinase activation. Immunopharmacology. 1999;41:21-9.
19. Costello MJ, Gewurz H, Siegel JN. Inhibition of neutrophil activation by alpha1-acid glycoprotein. Clin Exp Immunol. 1984;55:465-72.
20. Laine E, Couderc R, Roch-Arveiller M, Vasson MP, Giroud JP, Raichvarg D. Modulation of human polymorphonuclear neutrophil functions by alpha 1-acid glycoprotein. Inflammation. 1990;14:1-9.
21. Hochepied T, Van Molle W, Berger FG, Baumann H, Libert C. Involvement of the acute phase protein alpha 1-acid glycoprotein in nonspecific resistance to a lethal gram-negative infection. J Biol Chem. 2000;275:14903-9.
22. de Vries B, Walter SJ, Wolfs TG, Hochepied T, Rabina J, Heeringa P, et al. Exogenous alpha-1-acid glycoprotein protects against renal ischemia-reperfusion injury by inhibition of inflammation and apoptosis. Transplantation. 2004;78:1116-24.
23. Sorensson J, Ohlson M, Bjornson A, Haraldsson B. Orosomucoid has a cAMP-dependent effect on human endothelial cells and inhibits the action of histamine. Am J Physiol Heart Circ Physiol. 2000;278:H1725-31.
24. Janciauskiene SM, Nita IM, Stevens T. Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J Biol Chem. 2007;282:8573-82.
25. Chignard M, Balloy V. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol. 2000;279:L1083- 90.
26. Southam DS, Dolovich M, O'Byrne PM, Inman MD. Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol. 2002;282:L833-9.
27. Kushner I. Regulation of the acute phase response by cytokines. Perspect Biol Med. 1993;36:611-22.
28. Schreiber G, Tsykin A, Aldred AR, Thomas T, Fung WP, Dickson PW, et al. The acute phase response in the rodent. Ann N Y Acad Sci. 1989;557:61-85. discussion 85-6.
29. Heuertz RM, Piquette CA, Webster RO. Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. Am J Pathol. 1993;142:319-28.
30. Kilpatrick L, McCawley L, Nachiappan V, Greer W, Majumdar S, Korchak HM, et al. Alpha-1-antichymotrypsin inhibits the NADPH oxidase-enzyme complex in phorbol ester-stimulated neutrophil membranes. J Immunol. 1992;149:3059-65.
31. Libert C. Acute phase proteins as protective factors against the toxicity of tumor necrosis factor. Verh K Acad Geneeskd Belg. 1997;59:515-23.
32. Nagai A, Aoshiba K, Ishihara Y, Inano H, Sakamoto K, Yamaguchi E, et al. Administration of alpha 1-proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am Rev Respir Dis. 1992;145:651-6.
33. Churg A, Wang RD, Xie C, Wright JL. Alpha-1-antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med. 2003;168:199-207.
34. Nick JA, Young SK, Brown KK, Avdi NJ, Arndt PG, Suratt BT, et al. Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J Immunol. 2000;164:2151-9.
35. Nick JA, Young SK, Arndt PG, Lieber JG, Suratt BT, Poch KR, et al. Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase. J Immunol. 2002;169:5260-9.
36. Hill H, Bohnsack J, Morris E, Augustine N, Parker C, Cleary P, et al. Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J Immunol. 1988;141:3551-6.
37. Jagels M, Travis J, Potempa J, Pike R, Hugli T. Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect Immun. 1996;64:1984-91. (Pubitemid 26165656)
38. Rozdzinski E, Jones T, Burnette W, Burroughs M, Tuomanen E. Antiinflammatory effects in experimental meningitis of prokaryotic peptides that mimic selectins. J Infect Dis. 1993;168:1422-8.
39. Goldman D, Chang F, Gifford L, Goetzl E, Bourne H. Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes. J Exp Med. 1985;162:145-56.
40. Veldkamp K, Heezius H, Verhoef J, van Strijp J, van Kessel K. Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate. Infect Immun. 2000;68:5908-13.
41. Aoshiba K, Nagai A, Ishihara Y, Kagawa J, Takizawa T. Effects of alpha 1-proteinase inhibitor on chemotaxis and chemokinesis of polymorphonuclear leukocytes: its possible role in regulating polymorphonuclear leukocyte recruitment in human subjects. J Lab Clin Med. 1993;122:333-40.
42. Stockley RA, Bayley D, Hill SL, Hill AT, Crooks S, Campbell EJ. Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax. 2001;56(5):366-72.
43. Zuany-Amorim C, Haile S, Leduc D, Dumarey C, Huerre M, Vargaftig BB, et al. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest. 1995;95:2644-51.
44. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills- Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med. 1995;182:1527-36.
45. Kobbe P, Schmidt J, Stoffels B, Chanthaphavong RS, Bauer AJ, Pape HC. IL-10 administration attenuates pulmonary neutrophil infiltration and alters pulmonary iNOS activation following hemorrhagic shock. Inflamm Res. 2009;58:170-4.
46. Sun L, Guo RF, Newstead MW, Standiford TJ, Macariola DR, Shanley TP. Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge. Am J Respir Cell Mol Biol. 2008;41(1):76-84.
47. Cavusoglu E, Eng C, Chopra V, Clark LT, Pinsky DJ, Marmur JD. Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography. Arterioscler Thromb Vasc Biol. 2007;27:929-35.